Abstract Introduction: Eating disorders (EDs), particularly Anorexia Nervosa (AN), remain one of the most severe and treatment-resistant eating disorders, with…
Abstract Neuropathic pain, a debilitating condition, remains challenging to manage effectively. An insight into neuropharmacological mechanisms is critical for optimizing…
Abstract Background: Previous studies have shown mixed evidence on ethnic disparities in antipsychotic prescribing among patients with psychosis in the…
Abstract Background: Treatment-resistant epileptic seizures are associated with reduced quality of life (QoL). As polypharmacy with routine antiseizure medications has…
Abstract Background: With the recent legalization of cannabis for medical purposes in many countries, there has been an increased number…
Abstract Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging evidence points to CB2 playing…
Abstract “Medicinal cannabis” is defined as the use of cannabis-based products for the treatment of an illness. Investigations of cannabis…
Abstract Background: Tourette syndrome (TS) manifests with motor and vocal tics that can reach disabling intensity. Established therapies may show…
Abstract Cannabidiol (CBD) is gaining considerable attention in the research community with promising results in a variety of neuropsychiatric conditions.…
Abstract Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of disability. While there continues to be…